Low-Dosage 131I Therapy of Thyrotoxicosis (Diffuse Goiters): A Five-Year Follow-up Study

New England Journal of Medicine

Volumn 290, Issue 3, 1974, Pages 141-143

  Cevallos, Jose L ^a   Hagen, Garrett A ^a   Maloof, Farahe ^a   Chapman, Earle M ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POTASSIUM IODIDE; RADIOACTIVE IODINE; THYROTROPIN; THYROXINE;

ARTICLE; BLOOD; COMPARATIVE STUDY; FOLLOW UP; GRAVES DISEASE; HUMAN; HYPOTHYROIDISM; RADIATION DOSE; RADIOTHERAPY; TIME;

FOLLOW-UP STUDIES; GRAVES DISEASE; HUMANS; HYPOTHYROIDISM; IODINE RADIOISOTOPES; POTASSIUM IODIDE; RADIOTHERAPY; RADIOTHERAPY DOSAGE; THYROTROPIN; THYROXINE; TIME FACTORS;

EID: 0016395364     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM197401172900306     Document Type: Article

References (18)

1. Chapman EM, Maloof F: The use of radioactive iodine in the diagnosis and treatment of hyperthvroidism: ten years'experience. Medicine (Baltimore) 34: 261–321, 1955
2. Beling U, Einhorn J: Incidence of hypothyroidism and recurrences following I131 treatment of hyperthyroidism. Acta Radiol (Stockh) 56: 275–288, 1961
3. Dunn JT, Chapman EM: Rising incidence of hypothyroidism after radioactive-iodine therapy in thyrotoxicosis. N Engl J Med 271: 1037–1042, 1964
4. Nofal MM, Beierwaltes WH, Patno ME: Treatment of hyperthyroidism with sodium iodide I131: a 16-year experience. JAMA 197: 605–610, 1966
5. Hedley AJ, Flemming CJ, Chesters MI, et al: Surgical treatment of thyrotoxicosis. Br Med J 1: 519–523, 1970
6. Olsen WR, Nishiyama RH, Graber LW: Thyroidectomy for hyperthyroidism. Arch Surg 101: 175–180, 1970
7. Wood LC, Peterson M, Ingbar SH: Delayed thyroid failure and decreased reserve following antithyroid therapy in Graves' disease. Presented at the Forty-eighth Annual Meeting of the American thyroid Association, Chicago, Illinois, September 20–23, 1972, p 61
8. Hagen GA, Ouellette RP, Chapman EM: Comparison of high and low dosage levels of 131I in the treatment of thyrotoxicosis. N Engl J Med 277: 559–562, 1967
9. Murphy BEP, Pattee CJ: Determination of thyroxine utilizing the property of protein-binding. J Clin Endocrinol Metab 24: 187–196, 1964
10. Cassidy CE, Benotti J, Peno S: Clinical evaluation of the determination of thyroxine iodine. J Clin Endocrinol Metab 28: 420–421, 1968
11. Benotti J, Pino SC: Assay of serum thyroxine. II. Total thvroxine by competitive protein binding (displacement). Standard Method Clin Chem 7: 255–259, 1972
12. Ridgway EC, Weintraub BD, Cevallos JL, et al: Suppression of pituitary TSH secretion in the patient with a hyperfunctioning thyroid nodule. J Clin Invest 52: 2783–2792, 1973
13. Smith RN, Wilson GM: Clinical trial of different doses of 131I in treatment of thyrotoxicosis. Br Med J 1: 129–132, 1967
14. Glennon JA, Gordon ES, Sawin CT: Hypothyroidism after low-dose 131I treatment of hyperthyroidism. Ann Intern Med 76: 721–723, 1972
15. Blahd WH, Hays MT: Graves' disease in the male: a review of 241 cases treated with an individually calculated dose of sodium iodide I131. Arch Intern Med 129: 33–40, 1972
16. Rapoport B, Caplan R, DeGroot LJ: Low-dose sodium iodide I131 therapy in Graves disease. JAMA 224: 1610–1613, 1973
17. Hagen GA: Treatment of thyrotoxicosis with 131I and post-therapy hypothyroidism. Med Clin North Am 52: 417–429, 1968
18. Farid NR, Munro RE, Row VV, et al: Peripheral thvmus-dependent (T) lymphocytes in Graves's disease and Hashimoto's thyroiditis. N Engl J Med 288: 1313–1317, 1973